SCHEMBL19081859

SCHEMBL19081859

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5c(c4)oc4c5ccc5c4sc4ccc6ccccc6c45)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.34
CYP1A2 P05177 4/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
AHR P35869 1/20 0.34
PAX8 Q06710 1/20 0.34
ESR2 Q92731 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ESR1 P03372 1/20 0.32
CYP1B1 Q16678 4/20 0.32
PDE5A O76074 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082022 0.89 CYP1A1 (0.35) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19082002 0.89 ABCG2 (0.36) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19081933 0.88 ESR2 (0.33) ESR2ESR1PRKDC
SCHEMBL19082004 0.88 CYP1A1 (0.36) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19081856 0.87 ABCG2 (0.36) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19081987 0.86 CYP1A1 (0.36) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19081968 0.85 CYP1A1 (0.36) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL17944940 0.84 CYP1A1 (0.44) CYP1A1CYP1A2ABCG2KDM4EKMT2A
SCHEMBL19081861 0.84 CYP1A1 (0.37) CYP1A1CYP1A2ABCG2FYNMAPK3
SCHEMBL19081775 0.84 ALOX5 (0.34) CYP1A1CYP1A2ABCG2FYNMAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1A2 659/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1A2 659/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.